Literature DB >> 9083994

Mechanical fragmentation and pharmacologic thrombolysis in massive pulmonary embolism.

M Fava1, S Loyola, P Flores, I Huete.   

Abstract

PURPOSE: To evaluate the usefulness of mechanical fragmentation associated with intrapulmonary thrombolysis in acute massive pulmonary embolism (PE). PATIENTS AND METHODS: Sixteen cases of massive PE treated with mechanical fragmentation associated with pharmacologic thrombolysis were retrospectively studied. Severity of PE was assessed with the angiographic index according to the Urokinase Pulmonary Embolism Trial (maximum value of 18; score according to whether obstruction was central or peripheral, complete or partial). Mechanical fragmentation of the emboli was performed with angiographic catheters and angioplasty balloons. Urokinase was infused directly into the thrombus during the course of 8-24 hours. The effect of therapy was measured with direct pulmonary artery pressure (PAP) and blood O2 values.
RESULTS: Pre- and postinfusion angiographic index mean values (+/- standard deviation) were 13.7 +/- 1.4 and 6.1 +/- 2.2 (P < .0001). Mean pre- and postinfusion PAPs were 48.2 +/- 13.4 and 18.5 +/- 7.2 mm Hg (P < .0001). PaO2 increased from 60.1 +/- 12.1 to 88.7 +/- 23.4 mm Hg (P = .01). Fourteen patients (87.5%) completely recovered. One patient died during treatment despite improvement in PAP and PaO2 parameters. There were no major hemorrhagic complications.
CONCLUSIONS: The data support the efficacy of mechanical fragmentation associated with pharmacologic thrombolysis in the treatment of acute massive PE, resulting in improved hemodynamics and-blood oxygenation and in decreased PAP, with low morbidity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9083994     DOI: 10.1016/s1051-0443(97)70552-9

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  8 in total

1.  British Thoracic Society guidelines for the management of suspected acute pulmonary embolism.

Authors: 
Journal:  Thorax       Date:  2003-06       Impact factor: 9.139

Review 2.  When should we thrombolyse patients with pulmonary embolism? A systematic review of the literature.

Authors:  T Harris; S Meek
Journal:  Emerg Med J       Date:  2005-11       Impact factor: 2.740

3.  Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Clive Kearon; Elie A Akl; Anthony J Comerota; Paolo Prandoni; Henri Bounameaux; Samuel Z Goldhaber; Michael E Nelson; Philip S Wells; Michael K Gould; Francesco Dentali; Mark Crowther; Susan R Kahn
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

4.  Hybrid treatment with angiographic catheter in massive pulmonary embolism: mechanical fragmentation and fibrinolysis.

Authors:  S Pieri; P Agresti
Journal:  Radiol Med       Date:  2007-09-20       Impact factor: 3.469

5.  Mechanical interventions and thrombolytic therapy in venous thrombosis and pulmonary embolism.

Authors:  Rajesh Subramanian; Christopher J White
Journal:  Ochsner J       Date:  2002

Review 6.  Applications of thrombolytic therapy.

Authors:  N Curzen; R Haque; A Timmis
Journal:  Intensive Care Med       Date:  1998-08       Impact factor: 41.787

7.  Treatment of the acute severe pulmonary embolism using endovascular methods.

Authors:  Inger E Keussen; Carina Bursjoo; Wojciech Cwikiel
Journal:  Pol J Radiol       Date:  2018-06-01

8.  Efficacy and safety of 2-hour urokinase regime in acute pulmonary embolism: a randomized controlled trial.

Authors:  Chen Wang; Zhenguo Zhai; Yuanhua Yang; Yadong Yuan; Zhaozhong Cheng; Lirong Liang; Huaping Dai; Kewu Huang; Weixuan Lu; Zhonghe Zhang; Xiansheng Cheng; Ying H Shen
Journal:  Respir Res       Date:  2009-12-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.